Meeder Asset Management’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-540
Closed -$8K 1246
2021
Q3
$8K Hold
540
﹤0.01% 1743
2021
Q2
$12K Buy
+540
New +$8K ﹤0.01% 1623
2020
Q2
Sell
-1,580
Closed -$4K 2051
2020
Q1
$4K Buy
1,580
+1,567
+12,054% +$5.46K ﹤0.01% 1846
2019
Q4
$0 Buy
+13
New +$34 ﹤0.01% 2239
2019
Q3
Sell
-1,874
Closed -$6K 2137
2019
Q2
$6K Sell
1,874
-726
-28% -$2.25K ﹤0.01% 1599
2019
Q1
$8K Hold
2,600
﹤0.01% 1292
2018
Q4
$4K Buy
2,600
+243
+10% +$552 ﹤0.01% 1453
2018
Q3
$6K Buy
2,357
+1,506
+177% +$4.25K ﹤0.01% 1281
2018
Q2
$2.23K Buy
851
+70
+9% +$196 ﹤0.01% 1404
2018
Q1
$2K Sell
781
-132
-14% -$373 ﹤0.01% 1365
2017
Q4
$3K Buy
913
+719
+371% +$2.83K ﹤0.01% 1417
2017
Q3
$1K Sell
194
-464
-71% -$2.06K ﹤0.01% 1534
2017
Q2
$4K Buy
658
+113
+21% +$653 ﹤0.01% 1237
2017
Q1
$3K Sell
545
-945
-63% -$4.88K ﹤0.01% 1240
2016
Q4
$6K Buy
+1,490
New +$5.31K ﹤0.01% 832

Other funds holding AVXL